Tumor necrosis factor (TNF) can paradoxically increase on etanercept treatment, occasionally contributing to TNF-mediated disease.
Bhatia
Ajay
A
Kast
Richard E
RE
D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000276:immunology; D000075202:Contraindications; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000276:immunology; D011565:Psoriasis / Q000139:chemically induced* / Q000276:immunology; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology; D015398:Signal Transduction; D014409:Tumor Necrosis Factor-alpha / Q000097:blood* / Q000276:immunology
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept